The "Female VIAGRA" is HERE; FDA approves the Pink Pill

Medic-ALL (08:19:2015) SEXUAL HEALTH 

Up until now it was totally right to use the phrase "it's a man's world" when it concerned managing sexual dysfunction and improving sexual function and libido. But not anymore, as the United States Food and Drug Administration, FDA yesterday approved a counterpart for the men's "blue pill" in the form of the "Female Viagra" or if you like, "the Pink Pill.

The pill which is aimed at improving the female's desire for sex was approved after extensive lobbying campaign by the drug's makers, Sprout Pharmaceuticals, which has gone on for several months. In fact, there were campaigns launched by activist groups with petitions claiming that the lack of libido-enhancing drugs for women reflected "persistent gender inequality" at the FDA,since there were 26 government-approved drugs to treat sexual dysfunction in men.

The approved drug is called Flibanserin and will be marketed under the brand name Addyi. It is to be taken daily to treat pre-menopausal woman suffering from hypoactive sexual desire, which is a condition characterized by low sexual desire that causes marked distress or interpersonal  difficulty and is not due to to a co-existing medical or psychiatric condition, problems within a relationship or the effects of a medication or other drug substance. The FDA has asked the makers to specially train doctors and pharmacists who dispense it and keep track of any problems with women taking the drug. Hence, only trained physicians will be allowed to write prescriptions for the pill.

How exactly does it work?

Unlike Viagra and other men's erectile dysfunction medications which work by increasing blood flow to all parts of the body including the genitals, to improve a man's physical ability to have sex. Filbaserin modifies serotonin, a message carrying chemical in the human brain and is also said to increase the effects of desire-enhancing chemicals like dopamine. 

According to documents, the studies which compared Addyi with a placebo found that women using the drug had a median of 0.5 or 1.0 more satisfying sexual events a month, depending on the study. The median number of satisfactory sexual experiences each month before the drug test was two or three.

All Safe..?

The FDA is requiring a strong warning to women that the drug should never be taken while taking alcohol and there is also the risk of sudden loss of consciousness while taking the pill as well as the long term risk of taking a psychoactive drug daily for years. Women should also avoid taking Addyi with certain medications such as medications which are used to treat yeast infections.

As critics and supporters continue to debate the "controversial" approval and efficacy of the "Female Viagra", many consider it a huge advancement in women's health and many believe other medications will soon follow after "Addyi". However, as part of this approval, drug's makers have agreed to carry out further studies to ensure the safety of the new medication.

Medic-ALL Inc 2015!